Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 3425-3431, June 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, M. J.
Right arrow Articles by Corey, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, M. J.
Right arrow Articles by Corey, T. S.

Interleukin 2 Acutely Induces Platelet and Neutrophil-Endothelial Adherence and Macromolecular Leakage1

Michael J. Edwards2, Frederick N. Miller, David E. Sims, Deanna L. Abney, Dale A. Schuschke and Tracey S. Corey

Division of Surgical Oncology, Departments of Surgery [M. J. E., D. L. A.], Physiology [F. N. M., D. A. S.], and Pathology [T. S. C.], University of Louisville School of Medicine, Louisville, Kentucky 40292, and the Department of Anatomy and Physiology [D. E. S.], Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada, C1A 4P3

The acute effects of interleukin 2 (IL-2) were determined in the rat cremaster microcirculation model by intravital, light, and electron microscopy to better understand the pathophysiology of the IL-2-induced vascular leak syndrome. Four groups of rats were studied over a 2-h monitoring period. One group received 1 x 104 units of IL-2/kg i.v. (n = 10), while the remaining groups received IL-2 topically applied to the cremaster muscle in dosages of either 1 x 105 (n = 9), 1 x 106 (n = 5), or 3 x 106 (n = 5) units. Each group was compared with controls (n = 9). IL-2 administered i.v. acutely induced platelet and polymorphonuclear leukocyte-endothelial adherence and microvascular macromolecular leakage that occurred synchronous with the development of tachycardia, hypotension, tachypnea, and hypoxemia. Topically applied IL-2 induced similar microvascular alterations but without changes in hemodynamic and respiratory parameters, which suggests that microvascular alterations were not caused by IL-2-induced changes in hemodynamic parameters. Electron microscopy of cremaster muscle sections demonstrated platelet and neutrophil adherence to the endothelium and endothelial injury. We conclude that IL-2 (or a locally generated mediator) acutely induces platelet and neutrophil-endothelial adherence in the rat skeletal muscle microcirculation that is associated with the development of macromolecular leakage from the microcirculation.

1 Supported by American Cancer Society Clinical Oncology Career Development Award (CDA-90-178) (M. J. E.). Ultrastructural portions of this study were supported by a grant from the Heart and Stroke Foundation of Canada (D. E. S.).

2 To whom requests for reprints should be addressed, at the Department of Surgery, University of Louisville, Louisville, KY 40292.

Received 6/26/91. Accepted 4/ 3/92.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
A. L. Epstein, M. M. Mizokami, J. Li, P. Hu, and L. A. Khawli
Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability
J Natl Cancer Inst, May 21, 2003; 95(10): 741 - 749.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Hornick, L. A. Khawli, P. Hu, M. Lynch, P. M. Anderson, and A. L. Epstein
Chimeric CLL-1 Antibody Fusion Proteins Containing Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-2 With Specificity for B-Cell Malignancies Exhibit Enhanced Effector Functions While Retaining Tumor Targeting Properties
Blood, June 15, 1997; 89(12): 4437 - 4447.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.